In November 2010, the National Lung Screening Trial (NLST) announced results which identified a 20% relative reduction in lung cancer mortality from screening for lung cancer with low-dose computed tomography (LDCT) compared to Chest radiograph. These results, from a large and well-designed randomized controlled trial (RCT), prompted professional societies to advocate the use of LDCT screening in high risk populations.
News & Views
Find out what’s new at the Lung Cancer Research Foundation. Included below are researcher spotlights, recent developments in lung cancer research — from LCRF grant recipients as well as others in the field, highlights from our signature fundraising events and more.
For media inquiries, please contact Senior Director of Marketing & Communications Emily Krimbel at email@example.com.